Global Digital Pathology Market Size is valued at USD 1,173.9 Million in 2024 and is predicted to reach USD 3,981.2 Million by the year 2034 at a 13.1% CAGR during the forecast period for 2025-2034.
Digital pathology is the interpretation and administration of pathology data derived from digitalized glass slides. One of the most popular solutions for regular diagnostics and medication development has been digital pathology. Due to its many advantages, such as real-time sharing of streaming sites and digital photographs, digital pathology has grown. Integration of artificial intelligence (AI) with clinical data, machine learning (ML) allows for picture evaluation that goes beyond what is possible with classical histology.
Additionally, the launch of cloud-based technology allows the storage of digital slides associated with protected access to pathologists, which is predicted to contribute to the digital pathology market growth in the coming years. However, the high cost of these systems, coupled with the challenge of an absence of skilled personnel to operate digital pathology systems, is expected to limit the adoption of these systems.
The use of AI in healthcare is expanding as there is an increasing emphasis on enhancing patient care by applying AI to various healthcare services, such as pathological diagnosis. The growing demand for researcher cooperation and the expansion of digital documentation across all scientific disciplines drives the increased acceptance. The growing adoption of healthcare IT systems further boosts the digital pathology market demand.
The digital pathology market is segmented on a product, software, type, application and end users. Based on product, the market is divided into scanners, brightfield and other scanners. The market is segmented by software, integrated software, standalone software and storage systems. By type, the market is segmented into human pathology and veterinary pathology. By application, the market is segmented into drug discovery, disease diagnosis, training & education. By end users, the digital pathology market is segmented into pharmaceutical & biotechnology companies, hospitals and reference laboratories and academic & research institutes.
The disease diagnosis category is expected to hold a major global market share in 2024. Since it helps identify and comprehend the causes of diseases, digital diagnostics is essential in diagnosing many chronic diseases. The usage of digital pathology for routine diagnoses is rapidly expanding. The COVID-19 epidemic and its related social isolation barriers increased the demand for digital pathology. The market is significantly expanding due to the rising prevalence of cardiovascular illnesses and the growing demand for novel technologies to diagnose these conditions. Therefore, it is anticipated that the disease diagnosis segment will experience a significant increase over the projected period due to reasons such as the rising burden of infectious and chronic diseases and the integration of digital pathology.
The hospitals and reference laboratories segment is projected to grow rapidly in the global digital pathology market. The increase in hospital admissions for the treatment of chronic illnesses and the expansion of digital pathology tools and systems in the healthcare industry in industrialized nations. The market is also anticipated to increase due to strategic partnerships between hospitals and major market participants for the introduction of cutting-edge products. Clinical decision support systems and other AI-based solutions help hospitals streamline workflow procedures and improve medical care, which improves the patient experience.
North America is growing at a whopping rate in the global Digital Pathology market and undergoing a rapid transformation over the upcoming years. This is due to the rapidly rising occurrence of cancer, the launch of favorable reimbursement policies, increasing demand for quality diagnostics, and the increasing government initiatives by the government of Canada and the US are the essential elements driving the market growth in North America in forthcoming years.
Moreover, the Asia Pacific region is projected to grow rapidly in the global digital pathology market. The expansion can be linked to investments in the medical sector, untapped prospects in the Asia Pacific, and the increased adoption of digital imaging in emerging nations. Due to the rising incidence of cancer, which affects a major portion of the population, the healthcare sector in the Asia Pacific has significantly impacted the market. In addition, the region's market is anticipated to rise due to increased demand for novel treatment choices, improved patient care facilities, and lower laboratory costs.
|
Report Attribute |
Specifications |
|
Market size value in 2024 |
USD 1,173.9 Million |
|
Revenue forecast in 2034 |
USD 3,981.2 Million |
|
Growth rate CAGR |
CAGR of 13.1% from 2025 to 2034 |
|
Quantitative units |
Representation of revenue in US$ Mn,, and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report coverage |
The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends |
|
Segments covered |
Product, Type, Application And End Users |
|
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia |
|
Competitive Landscape |
Leica Microsystems (Germany), Hamamatsu Photonics K.K. (Japan), Nikon Corporation (Japan), Visio pharm A/S (Denmark), Coinlike Philips N.V.(Netherlands), F. Hoffmann-La Roche Ltd (Switzerland), Glencoe Software, Inc. (U.S.), XIFIN, Inc. (U.S.) and PerkinElmer Inc. (U.S.) |
|
Customization scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and available payment methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Digital Pathology Market Snapshot
Chapter 4. Global Digital Pathology Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Product Type Estimates & Trend Analysis
5.1. by Product Type & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Product Type:
5.2.1. Scanners
5.2.1.1. Brightfield
5.2.1.2. Other Scanners
5.2.2. Software
5.2.2.1. Integrated Software
5.2.2.2. Standalone Software
5.2.2.2.1. Information Management Software
5.2.2.2.2. Image Analysis Software
5.2.3. Storage Systems
Chapter 6. Market Segmentation 2: by Type Estimates & Trend Analysis
6.1. by Type & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Type:
6.2.1. Human Pathology
6.2.2. Veterinary Pathology
Chapter 7. Market Segmentation 3: by Application Estimates & Trend Analysis
7.1. by Application & Market Share, 2024 & 2034
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Application:
7.2.1. Drug Discovery
7.2.2. Disease Diagnosis
7.2.3. Training & Education
Chapter 8. Market Segmentation 4: by End User Estimates & Trend Analysis
8.1. by End User & Market Share, 2024 & 2034
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by End User:
8.2.1. Pharmaceutical & Biotechnology Companies
8.2.2. Hospitals and Reference Laboratories
8.2.3. Academic & Research Institutes
Chapter 9. Digital Pathology Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Digital Pathology Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
9.1.2. North America Digital Pathology Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
9.1.3. North America Digital Pathology Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.1.4. North America Digital Pathology Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
9.1.5. North America Digital Pathology Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.2. Europe
9.2.1. Europe Digital Pathology Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
9.2.2. Europe Digital Pathology Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
9.2.3. Europe Digital Pathology Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.2.4. Europe Digital Pathology Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
9.2.5. Europe Digital Pathology Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.3. Asia Pacific
9.3.1. Asia Pacific Digital Pathology Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
9.3.2. Asia Pacific Digital Pathology Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
9.3.3. Asia-Pacific Digital Pathology Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.3.4. Asia-Pacific Digital Pathology Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
9.3.5. Asia Pacific Digital Pathology Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.4. Latin America
9.4.1. Latin America Digital Pathology Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
9.4.2. Latin America Digital Pathology Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
9.4.3. Latin America Digital Pathology Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.4.4. Latin America Digital Pathology Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
9.4.5. Latin America Digital Pathology Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.5. Middle East & Africa
9.5.1. Middle East & Africa Digital Pathology Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
9.5.2. Middle East & Africa Digital Pathology Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
9.5.3. Middle East & Africa Digital Pathology Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.5.4. Middle East & Africa Digital Pathology Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
9.5.5. Middle East & Africa Digital Pathology Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Biosystems (US)
10.2.2. Koninklijke Philips N.V. (Netherlands)
10.2.3. Hamamatsu Photonics (Japan)
10.2.4. F. Hoffmann-La Roche Ltd. (Switzerland)
10.2.5. 3DHISTECH (Hungary)
10.2.6. Apollo Enterprise Imaging (US)
10.2.7. XIFIN, Inc. (US)
10.2.8. Huron Digital Pathology (Canada)
10.2.9. Visiopharm A/S (Denmark)
10.2.10. Aiforia Technologies Oy (Finland)
10.2.11. Akoya Biosciences (US)
10.2.12. Corista (US)
10.2.13. Indica Labs (US)
10.2.14. Objective Pathology Services (Canada)
10.2.15. Sectra AB (Sweden)
10.2.16. OptraSCAN (US)
10.2.17. Glencoe Software (US)
10.2.18. KONFOONG BIOTECH INTERNATIONAL CO., LTD. (China)
10.2.19. Inspirata, Inc. (US)
10.2.20. PathAI (US)
10.2.21. Proscia Inc. (US)
10.2.22. Kanteron Systems (Spain)
10.2.23. Mikroscan Technologies (US)
10.2.24. Motic (US)
10.2.25. Paige (US)
10.2.26. Other Prominent Players
Digital Pathology Market By Product
Digital Pathology Market By Type
Digital Pathology Market By Application
Digital Pathology Market By End User
Digital Pathology Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
